Shifa J, Adams J, Demant D
BMC Psychiatry. 2025; 25(1):151.
PMID: 39972261
PMC: 11841329.
DOI: 10.1186/s12888-025-06550-8.
Jones A, Marwan Abu Taha A, Miller G
Neurosci Biobehav Rev. 2025; 170:106043.
PMID: 39922438
PMC: 11870277.
DOI: 10.1016/j.neubiorev.2025.106043.
Cummins K, Brumback T, Corrales C, Nooner K, Brown S, Clark D
PLOS Glob Public Health. 2024; 4(10):e0003545.
PMID: 39436876
PMC: 11495575.
DOI: 10.1371/journal.pgph.0003545.
Nikolova Y, Ruocco A, Felsky D, Lange S, Prevot T, Vieira E
medRxiv. 2024; .
PMID: 39252904
PMC: 11383479.
DOI: 10.1101/2024.08.30.24312806.
Cai W, Forsell Y, Lavebratt C, Melas P
Sci Rep. 2024; 14(1):17566.
PMID: 39080362
PMC: 11289395.
DOI: 10.1038/s41598-024-68578-2.
Young adults with a history of substance use disorder experienced more negative mental health, social and economic outcomes during the COVID-19 pandemic period.
Halvorson M, Kuklinski M, Bailey J, Caouette J, Guttmannova K, Rhew I
Addiction. 2024; 119(9):1597-1607.
PMID: 38923042
PMC: 11415070.
DOI: 10.1111/add.16582.
Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder.
White A, Eglovitch M, Parlier-Ahmad A, Dzierzewski J, James M, Bjork J
PLoS One. 2024; 19(6):e0304461.
PMID: 38870144
PMC: 11175529.
DOI: 10.1371/journal.pone.0304461.
Gene × environment effects and mediation involving adverse childhood events, mood and anxiety disorders, and substance dependence.
Kranzler H, Davis C, Feinn R, Jinwala Z, Khan Y, Oikonomou A
Nat Hum Behav. 2024; 8(8):1616-1627.
PMID: 38834750
DOI: 10.1038/s41562-024-01885-w.
Substance Use, Sleep Duration, and Health Among Adults in Ohio.
Hernandez E, Griggs S
Prev Chronic Dis. 2023; 20:E117.
PMID: 38154118
PMC: 10756651.
DOI: 10.5888/pcd20.230198.
Gender, homelessness, hospitalization and methamphetamine use fuel depression among people who inject drugs: implications for innovative prevention and care strategies.
Moulis L, Le S, Hai V, Huong D, Minh K, Oanh K
Front Psychiatry. 2023; 14:1233844.
PMID: 38025448
PMC: 10661402.
DOI: 10.3389/fpsyt.2023.1233844.
Polysubstance use in inflammatory bowel disease is associated with increased risk of emergency department visits: a longitudinal study.
Bogale K, Zubrzycka I, Stuart A, Cesaire M, Walter V, Tinsley A
Ann Gastroenterol. 2023; 36(6):630-636.
PMID: 38023977
PMC: 10662067.
DOI: 10.20524/aog.2023.0835.
Adverse Childhood Events, Mood and Anxiety Disorders, and Substance Dependence: Gene x Environment Effects and Moderated Mediation.
Kranzler H, Davis C, Feinn R, Jinwala Z, Khan Y, Oikonomou A
Res Sq. 2023; .
PMID: 37961429
PMC: 10635374.
DOI: 10.21203/rs.3.rs-3483320/v1.
Adverse Childhood Events, Mood and Anxiety Disorders, and Substance Dependence: Gene X Environment Effects and Moderated Mediation.
Kranzler H, Davis C, Feinn R, Jinwala Z, Khan Y, Oikonomou A
medRxiv. 2023; .
PMID: 37961309
PMC: 10635185.
DOI: 10.1101/2023.10.24.23297419.
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access.
Petersen E, Augustsson H, Berman A
Addict Sci Clin Pract. 2023; 18(1):65.
PMID: 37875999
PMC: 10594773.
DOI: 10.1186/s13722-023-00421-x.
Are novel treatments for brain disorders hiding in plain sight?.
Duncan L, Deisseroth K
Neuropsychopharmacology. 2023; 49(1):276-281.
PMID: 37422511
PMC: 10700299.
DOI: 10.1038/s41386-023-01636-x.
Evidence-Based Assessment of Substance Use Disorder.
Boness C, Gonzalez J, Sleep C, Venner K, Witkiewitz K
Assessment. 2023; 31(1):168-190.
PMID: 37322848
PMC: 11059671.
DOI: 10.1177/10731911231177252.
Assessing cross-lagged associations between depression, anxiety, and binge drinking in the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study.
McCabe C, Brumback T, Brown S, Meruelo A
Drug Alcohol Depend. 2023; 243:109761.
PMID: 36621201
PMC: 10122417.
DOI: 10.1016/j.drugalcdep.2022.109761.
Directional associations between cannabis use and anxiety symptoms from late adolescence through young adulthood.
Davis J, Pedersen E, Tucker J, Prindle J, Dunbar M, Rodriguez A
Drug Alcohol Depend. 2022; 241:109704.
PMID: 36434880
PMC: 9810069.
DOI: 10.1016/j.drugalcdep.2022.109704.
Changes in Tobacco and Alcohol Consumption in France during the Spring 2020 Lockdown: Results of the Coviprev and Viquop Surveys.
Quatremere G, Guignard R, Andler R, Sempe S, Houzelle N, Nguyen-Thanh V
Int J Environ Res Public Health. 2022; 19(22).
PMID: 36429526
PMC: 9690956.
DOI: 10.3390/ijerph192214808.
Overdose Experiences among People Who Inject Drugs in West Virginia: Personal Loss, Psychological Distress, Naloxone, and Fentanyl.
Schneider K, Allen S, Winiker A, White R, ORourke A, Sherman S
Subst Use Misuse. 2022; 58(1):22-26.
PMID: 36371695
PMC: 10124002.
DOI: 10.1080/10826084.2022.2136489.